Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences , Peking University , Beijing 100191 , China.
School of Pharmacy , Shenyang Pharmaceutical University , Shenyang 110016 , China.
ACS Nano. 2019 May 28;13(5):5058-5076. doi: 10.1021/acsnano.8b07231. Epub 2019 May 6.
Overcoming the epithelial barriers to enhance drug transport is a focused topic for gastrointestinal, intratracheal, intranasal, vaginal, and intrauterine delivery. Nanomedicines with targeting functionization promote such a process owing to specific ligand-receptor interaction. However, compared to the cell uptake of targeting nanotherapies, currently few studies concentrate on their transcytosis including endocytosis for "in" and exocytosis for "out". In fact, the cellular regulatory mechanism for these pathways as well as the principle of ligand's effect on the transcytosis are almost ignored. Here, we fabricated transferrin (Tf) functionalized nanogranules (Tf-NG) as the nanomedicine model and confirmed the difference in polar distributions of Tf receptors (TfRs) between two epithelium models (bipolarity for Caco-2 and unipolarity for MDCK cells). Compared to the nonspecific reference, Tf-conjugation boosted the endocytosis by different pathways in two cell models and transformed the intracellular route of Tf-NG in both cells differently, affecting exocytosis, recycling, and degradation but not the secretion pathway. Only bipolar cells could establish a complete transport flow from "in" to "out", leading to the enhanced transcytosis of Tf-NG. Importantly, epithelia could make responses to Tf-NG transcytosis. Based on the quantitative proteomics, the intracellular trafficking of Tf-NG altered the protein expression profiles, in which the endocytosis- and transcytosis-related proteins were specifically upregulated. Particularly, only bipolar cells could positively feed back to such trafficking via accelerating the subsequent Tf-NG transcytosis. Here, all the cell transport of Tf-NG was polarity associated. In summary, Tf modification elevated the transcytosis of Tf-NG across the epithelium by triggering the polarity-associated transport flow and positive cell feedback loop. These findings provided an insight into the targeting nanodelivery for efficient transport through epithelial barriers.
克服上皮屏障以增强药物传输是胃肠道、气管内、鼻内、阴道和子宫内给药的一个重点研究课题。具有靶向功能化的纳米药物由于特定的配体-受体相互作用而促进了这一过程。然而,与靶向纳米疗法的细胞摄取相比,目前很少有研究集中在它们的转胞吞作用上,包括内吞作用(“进入”)和胞吐作用(“出去”)。事实上,这些途径的细胞调节机制以及配体对转胞吞作用的影响原则几乎被忽略。在这里,我们制备了转铁蛋白(Tf)功能化纳米颗粒(Tf-NG)作为纳米药物模型,并证实了两种上皮模型(Caco-2 的双极性和 MDCK 细胞的单极性)中 Tf 受体(TfR)的极性分布差异。与非特异性对照相比,Tf 缀合通过两种细胞模型中的不同途径促进了内吞作用,并以不同的方式改变了两种细胞中 Tf-NG 的细胞内途径,影响了胞吐作用、回收和降解,但不影响分泌途径。只有双极性细胞才能建立从“进入”到“出去”的完整运输流,从而增强 Tf-NG 的转胞吞作用。重要的是,上皮细胞可以对 Tf-NG 的转胞吞作用做出反应。基于定量蛋白质组学,Tf-NG 的细胞内运输改变了蛋白质表达谱,其中内吞作用和转胞吞作用相关蛋白被特异性上调。特别是,只有双极性细胞才能通过加速随后的 Tf-NG 转胞吞作用来对此类运输做出积极反馈。在这里,Tf-NG 的所有细胞运输都与极性相关。总之,Tf 修饰通过触发与极性相关的运输流和阳性细胞反馈环,提高了 Tf-NG 在上皮屏障中的转胞吞作用。这些发现为通过上皮屏障的高效靶向纳米递药提供了新的见解。